Meanwhile, [11C]6 has successfully been used to demonstrate downregulation of PDE4 in major depressive disorder [80] and to monitor progression of certain cardiac disorders such as heart failure, mitral valve disease, diabetic cardiomyopathy, and adriamycin cardiotoxicity [81]. Here, PDE4A is linked to major depressive disorder.